Amyloid

Finding the ‘goldilocks’ zone for Alzheimer’s disease immunotherapies

Manipulation of the immune system for Alzheimer’s disease therapy

Late-life major depression impacts plasma Aβ dynamics

Immune activation states in Alzheimer’s disease mouse models

AI with advanced retinal imaging techniques to detect neurodegenerative disease risk markers

Amyloid prediction models for use in the general population

Visual versus quantitative analysis of tau-PET

Why Alzheimer’s disease research is focusing on tau

Advantages of tau-PET compared to amyloid-PET

Time gap between amyloid- and tau-PET positivity in preclinical disease

24-hour activity rhythms associated with amyloid levels after 8 years

Digital markers detect changes in neurocognitive performance in those with vs without hearing loss

Exploring the potential role of amyloid deposition in the gut in Alzheimer’s disease

Mechanistic links between depressive symptoms and cognitive deficits

Blood biomarkers for the differential diagnosis of Alzheimer’s disease in clinical practice

Relationship between amyloid and tau modulated by astrocyte reactivity